ACC 2022

METEORIC-HF: The Effect of Omecamtiv Mecarbil on Exercise Tolerance In Patients with Chronic Heart Failure and Reduced Ejection Fraction

C. Michael Gibson and Gregory Lewis discuss the METEORIC-HF trial presented at ACC 2022.

We Recommend